For full functionality of this website it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser

Session Details

ScaleReady: Redefining Sustainability in CGT: Ensuring Affordability and Accessibility Through Strategic Innovations
Thursday, May 30, 2024 07:00 AM - 08:00 AM  
Room 217-219
Corporate Session
Moderator:
  • Josh Ludwig, Commercial Director, ScaleReady, United States
Panelists:
  • Carol Houts, Chief Strategy Officer, GermFree, United States
  • Edwin Stone, MEng, PhD, CEO, Cellular Origins, United States
  • Ignacio Nunez, MSc, COO, CellReady, United States
     
The session will commence with presentations from each of the panelists, each diving into an introduction to new sustainability paradigms in cell and gene therapy (CGT), moving beyond traditional environmental concerns to encompass economic and operational dimensions. Discussions will emphasize the critical role of sustainability in ensuring the affordability and accessibility of CGT treatments for patients. As a key component of sustainability, cost management will be explored, with a focus on strategies to minimize both direct and indirect financial waste. Practical examples will illustrate cost-effective practices within CGT development and delivery, highlighting the often overlooked relationship between cost levels and environmental impact.
 
The session will discuss optimizing and transforming operations to bolster sustainability. This includes identifying and addressing common operational inefficiencies, such as space utilization and process flow, and discussing how these optimizations contribute to sustainable practices and cost reductions. The concept of transformational change will be addressed, emphasizing its necessity when optimization alone is insufficient.
 
As a key message to sustainability in CGT,  "The Infinite Game" concept will be introduced and perspectives discussed, such as long-term thinking in the context of business and operational sustainability within CGT. This section will cover the importance of long-term planning and flexibility to avoid costly future adjustments and enhance sustainability. Concrete actions that therapeutic developers of all sizes can implement today will be outlined, providing attendees with actionable insights to take back to their organizations.
 
The session will end with a 15-minute panel discussion and audience Q&A

Session Objectives:
  • Recognizing that sustainability in CGT also encompasses economic and operational stability.
  • Learning practical approaches to minimize costs and enhance operational efficiency within their organizations.
  • Gaining knowledge on the benefits of long-term strategic planning to avoid future costs and ensure sustainable growth.
  • Identifying areas of waste in their operations and strategies to eliminate them, enhancing both sustainability and profitability.
  • Understanding how these sustainability strategies ultimately lead to more accessible and affordable treatments for patients.

SPONSORED BY:
Carol Ann Houts
CSO
Germfree Laboratories
Panelist


Josh Ludwig
Global Director, Commercial Operations
ScaleReady
Moderator


Edwin Stone
CEO
Cellular Origins
Panelist


Ignacio Nunez
COO
CellReady
Panelist